Ascendis Pharma As Stock Price on December 12, 2024
| ASND Stock | USD 139.70 3.32 2.43% |
Below is the normalized historical share price chart for Ascendis Pharma AS extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ascendis Pharma stands at 139.70, as last reported on the 25th of December, with the highest price reaching 140.47 and the lowest price hitting 135.61 during the day.
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of -0.0282, which signifies that the company had a -0.0282% return per unit of standard deviation over the last 3 months. Ascendis Pharma AS exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ascendis Pharma's risk adjusted performance of (0.03), and Mean Deviation of 1.73 to double-check the risk estimate we provide.
At present, Ascendis Pharma's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 70 M, whereas Common Stock Total Equity is forecasted to decline to about 4.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.79, whereas Price To Sales Ratio is forecasted to decline to 22.84. Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of January 2015 | 200 Day MA 135.1101 | 50 Day MA 129.5369 | Beta 0.654 |
Ascendis |
Sharpe Ratio = -0.0282
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASND |
Estimated Market Risk
| 2.18 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ascendis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding Ascendis Pharma to a well-diversified portfolio.
Price Book 14.5547 | Enterprise Value Ebitda (20.75) | Price Sales 26.3013 | Shares Float 56.9 M | Wall Street Target Price 191.9323 |
Ascendis Pharma Main Headline on 12th of December 2024
FDA Accepts Ascendis Pharmas Supplemental Biologics License ... by finance.yahoo.com
PDUFA goal date is July 27, 2025COPENHAGEN, Denmark, Dec. 12, 2024 -- Ascendis Pharma AS today announced that the U.S. Food Drug Administration has accepted for review its supplemental Biologics License Application in adult growth hormone deficiency for TransCon hGH . The FDA set a Prescription Drug User Fee Act goal date of July 27, 2025. This marks another step toward
Ascendis Pharma Valuation on December 12, 2024
It is possible to determine the worth of Ascendis Pharma on a given historical date. On December 12, 2024 Ascendis was worth 133.98 at the beginning of the trading date compared to the closed value of 130.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascendis Pharma stock. Still, in general, we apply an absolute valuation method to find Ascendis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascendis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascendis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 130.08 | 134.82 | 127.57 | 134.28 | 399,109 | |
12/12/2024 | 133.98 | 135.71 | 130.17 | 130.64 | 403,025 |
| 129.57 | 131.37 | 128.45 | 129.87 | 239,524 |
| Backtest Ascendis Pharma | | | Ascendis Pharma History | | | Ascendis Pharma Valuation | Previous | Next |
Ascendis Pharma Trading Date Momentum on December 12, 2024
| On December 13 2024 Ascendis Pharma AS was traded for 129.87 at the closing time. The top price for the day was 131.37 and the lowest listed price was 128.45 . The trading volume for the day was 239.5 K. The trading history from December 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.59% . The overall trading delta against the current closing price is 5.08% . |
Ascendis Pharma AS Fundamentals Correlations and Trends
By evaluating Ascendis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascendis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascendis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.3 M | 39.2 M | |
| Net Loss | -524.9 M | -498.6 M |
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ascendis Pharma Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Ascendis Pharma AS cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ascendis Pharma December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.20) | |||
| Treynor Ratio | 0.4804 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |